Cascade Funding: $66M Raised, Series D (2026)

Cascade funding overview

Cascade is based in Shanghai, China. Cascade has raised $66M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series D announced in June 2026. The round record for Cascade runs through 2026; nothing later has been disclosed. Investors on record include Taiping Medical Health Fund, Shanghai STVC Group, Yuekai Capital, Zhaode Investment, Lianbang Fund, Puhua Capital and 1 others. 7 distinct backers are named across the disclosed rounds.

Cascade at a glance

Total raised: $66M
Latest round: Series D
Latest round date: June 2026
Headquarters: Shanghai, China
Notable investors: Taiping Medical Health Fund, Shanghai STVC Group, Yuekai Capital, Zhaode Investment, Lianbang Fund, Puhua Capital, Chinese Academy of Sciences

Frequently asked about Cascade funding

How much has Cascade raised?: Cascade has raised $66M in total disclosed funding across the rounds on record.
Who has invested in Cascade?: Taiping Medical Health Fund, Shanghai STVC Group, Yuekai Capital, Zhaode Investment, Lianbang Fund, Puhua Capital are named among the investors backing Cascade.
What was the latest Cascade funding round?: The most recent disclosed round is a Series D, announced in June 2026.
Where is Cascade based?: Cascade is based in Shanghai, China.
When did Cascade last raise?: The last disclosed Cascade round closed in June 2026 at Series D.

We update the Cascade record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Shanghai and their backers are listed below.

Cascade Funding: $66M Raised, Series D (2026)

Cascade funding overview

Cascade at a glance

Frequently asked about Cascade funding

Companies related to Cascade (18)

Browse related funding lists (6)